530163
Kerala Ayurveda financials
- Market cap
- ₹226 Cr
- Sector
- Healthcare
What Kerala Ayurveda does
Kerala Ayurveda Limited manufactures and sells Ayurvedic herbal formulations and consumer wellness products, including its patented K-series range (K-10, K-10 Plus, K-13, K-13 Plus, K-1) targeted at blood-sugar control, inflammation/pain management and obesity, alongside products like Chyavanaprash, Swarnamukhi, Balakalpam and Myaxil. It runs Ayurvedic treatment/wellness facilities (including a hospital and the Ayurvedagram Heritage Wellness Centre) and a raw-drug processing unit in Kerala, and operates the Kerala Ayurveda Academy & Wellness Center in Milpitas, California, which offers Ayurvedic practitioner certifications, clinical internships and consultations. Through a joint venture with Sanghvi Brands Ltd, the company also develops and operates Ayurvedagram-branded wellness resorts and Ayurvedic spas within luxury hotels.
Segments
- Ayurvedic products & formulations
- Wellness centres, clinics & hospital
- US Academy & wellness center
- Ayurvedagram Wellness Resorts & Spas (JV with Sanghvi Brands)
- Manufacturing & operating units (Aluva/Kerala)
- 4 (Raw Drug Division-Kottai Nedumbaserry, Health Village-Aluva, KAL Hospital-Aluva, FG Depot-Panaikulam)
- Customers served (US distribution)
- 11,000+
- US Academy students & alumni
- 2,000+
- US Academy accredited content
- 6,000+ hours
- Land bank
- ~12.5 acres (8.5 acres at Manyali for Ayurvedagram Resort + 4 acres in Kerala for a new factory)
- JV partner (Sanghvi Brands) spa/wellness footprint
- 70+ locations globally (India, Middle East, Sri Lanka, USA)
Quarterly results
Q1 FY27: revenue up 28.2%, net profit down 470.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19 | 19 | 19 | 18 | 21 +14% | 22 +14% | 25 +27% | 23 +28% |
| EBITDA | -1 | 0 | -11 | -5 | -5 −816% | -2 −659% | -10 +4% | -5 +6% |
| Net profit | -1 | -0 | -12 | 2 | -5 −900% | -3 −4237% | -8 +33% | -8 −471% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −64.5% 1Y
1Y: ₹489.55 on 10 Sept 2025 → ₹173.65. High ₹489.55 (10 Sept 2025), low ₹148.95 (7 Aug 2026).
Financials, as filed
Revenue grew 1.6% a year over 3 years, FY23 to FY26. Operating margin narrowed to -26.9%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹81 Cr | ₹68 Cr | ₹73 Cr | ₹86 Cr |
| Operating profit | ₹2 Cr | ₹3 Cr | ₹-13 Cr | ₹-23 Cr |
| Operating margin | 2.4% | 5.1% | -17.3% | -26.9% |
| Interest | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹7 Cr |
| Depreciation | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr |
| Net profit | ₹-0 Cr | ₹0 Cr | ₹-14 Cr | ₹-15 Cr |
| Net margin | -0.3% | 0.1% | -18.9% | -17.2% |
| Cash from operations | ₹9 Cr | ₹-5 Cr | ₹2 Cr | ₹-25 Cr |
| Free cash flow | ₹8 Cr | ₹-6 Cr | ₹-5 Cr | ₹-28 Cr |
| ROCE | 6.0% | 6.0% | -11.0% | -9.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr | ₹13 Cr |
| Reserves | ₹-1 Cr | ₹1 Cr | ₹4 Cr | ₹21 Cr | ₹-7 Cr | ₹23 Cr |
| Borrowings | ₹66 Cr | ₹61 Cr | ₹64 Cr | ₹64 Cr | ₹85 Cr | ₹74 Cr |
| Other liabilities | ₹20 Cr | ₹19 Cr | ₹21 Cr | ₹20 Cr | ₹45 Cr | ₹30 Cr |
| Total liabilities | ₹96 Cr | ₹92 Cr | ₹99 Cr | ₹116 Cr | ₹135 Cr | ₹140 Cr |
| Fixed assets | ₹26 Cr | ₹28 Cr | ₹30 Cr | ₹28 Cr | ₹49 Cr | ₹34 Cr |
| Capital work in progress | ₹2 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹9 Cr | ₹1 Cr |
| Investments | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹9 Cr | ₹0 Cr | ₹9 Cr |
| Other assets | ₹56 Cr | ₹50 Cr | ₹57 Cr | ₹79 Cr | ₹78 Cr | ₹95 Cr |
| Total assets | ₹96 Cr | ₹92 Cr | ₹99 Cr | ₹116 Cr | ₹135 Cr | ₹140 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters trimmed −2.23 pp while the public added +2.06 pp. The shareholder count grew 10% to 10,372.
- Promoters
- 35.6%
- FIIs
- 0.2%
- DIIs
- 0.0%
- Public
- 64.2%
Since Jun 2025
- Promoters −2.23 pp
- Public +2.06 pp
- FIIs +0.17 pp
How it drifted, 12 quarters
Over this window promoters fell from 61.5% to 35.6% — −25.9 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 61.5%, DIIs 0.1%, Public 38.4%.Dec '23: Promoters 63.4%, DIIs 0.1%, Public 36.5%.Mar '24: Promoters 58.6%, DIIs 0.0%, Public 41.4%.Jun '24: Promoters 58.6%, DIIs 0.0%, Public 41.4%.Sep '24: Promoters 58.6%, DIIs 0.0%, Public 41.4%.Dec '24: Promoters 58.6%, DIIs 0.0%, Public 41.4%.Mar '25: Promoters 58.6%, DIIs 0.0%, Public 41.4%.Jun '25: Promoters 37.8%, DIIs 0.0%, Public 62.1%.Sep '25: Promoters 33.1%, DIIs 0.0%, Public 66.8%.Dec '25: Promoters 33.1%, FIIs 0.2%, DIIs 0.0%, Public 66.6%.Mar '26: Promoters 35.6%, FIIs 0.2%, DIIs 0.0%, Public 64.2%.Jun '26: Promoters 35.6%, FIIs 0.2%, DIIs 0.0%, Public 64.2%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Sreerangam Kunjupanicker Arunkumar newly disclosed 1.17% held
The same filing shows 2 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Kerala Ayurveda above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Katra Holdings Ltd | 30.75% | unchanged |
| Katra Holding Private Limited | 4.85% | unchanged |
| Porinju Veliyath | 3.41% | −0.08 pp |
| Sanjiv Dhireshbhai Shah | 2.51% | unchanged |
| Santosh Industries Limited | 1.85% | unchanged |
| Suresh Bhatia Huf | 1.77% | unchanged |
| Dheeraj Kumar Lohia | 1.60% | unchanged |
| Aamara Capital Private Limited | 1.33% | unchanged |
| Utsav Rasiklal Kapadia | 1.33% | unchanged |
| Anil Kumar K | 1.29% | unchanged |
| Sangeetha Arunkumar | 1.17% | unchanged |
| Sreerangam Kunjupanicker Arunkumar | 1.17% | newly disclosed |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Kerala Ayurveda
Guides on how to read this kind of business and the numbers that matter.